info:eu-repo/semantics/article
Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: A new endocrine system in metabolic syndrome
Fecha
2013-06Registro en:
Pirola, Carlos José; Fernández Gianotti, Tomás; Castaño, Gustavo Osvaldo; Sookoian, Silvia Cristina; Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: A new endocrine system in metabolic syndrome; John Wiley & Sons Inc; Hepatology (Baltimore, Md.); 57; 6; 6-2013; 2545-2547
0270-9139
CONICET Digital
CONICET
Autor
Pirola, Carlos José
Fernández Gianotti, Tomás
Castaño, Gustavo Osvaldo
Sookoian, Silvia Cristina
Resumen
To the Editor: We read with great interest the article by Bala et al. about the role of circulating microRNAs (miRNAs) as markers of alcohol‐ and acetaminophen‐induced liver damage in a mouse model; the investigators concluded that circulating miR‐122 and miR‐155 may serve as biomarkers of liver injury and inflammation, respectively.